Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2019 Dec;12(1):e007495. doi: 10.1161/CIRCIMAGING.117.007495

Table 4:

Multivariable Associations of RA Participant Characteristics with LVMI

LV mass index Model 1
n=72
Model 2
n=72
β p β P
MFR global −1.8403 0.007 −2.0874 0.008
Age, per year 0.0894 0.49
Race/ethnicity
 Non-Hispanic white ref Ref ref Ref
 Non-Hispanic black 1.5479 0.49 1.7415 0.343
 Hispanic 3.6751 0.024 3.6076 0.013
Hypertension, yes v no −0.4099 0.81
Diabetes, yes v. no 1.076 065
HDL, per mg/dL −0.0129 0.73
log triglycerides, per unit −0.6970 0.72
RF or anti-CCP, yes v. no 2.5564 0.082 2.4703 0.063
DAS28-CRP
 DAS28-CRP<2.6 Ref Ref ref Ref
 DAS28-CRP 2.6-4.1 2.6664 0.12 2.3467 0.13
 DAS28-CRP>4.1 4.3491 0.032 4.1895 0.022
HAQ, per unit −1.9814 0.056 −1.5833 0.062
Median IL-6, per unit 0.4385 0.75
CAC score
 CAC score zero Ref ref
 CAC score 1-99 −1.2262 0.54
 CAC score ≥100 −0.3529 0.87
ACE-inhibitor use 3.6773 0.075 4.6417 0.001
Statin use 0.7441 0.71

Prob>F 0.005 <0.00001
Unadjusted R2 0.4437 0.4094

Model 1 covariates are derived from table 2 where any variable with a p<0.2 was included. BMI was not included due to collinearity with LVMI which is indexed by height. Model 2 is a reduced model that includes all of the covariates from Model 1 with p values < 0.2. RF: rheumatoid factor, CCP: cyclic citrullinated protein antibody, DAS: disease activity score, HDL: high density lipoprotein, CRP: C-reactive protein, IL-6: interleukin 6, MFR: myocardial blood flow reserve, CAC: coronary artery calcium.